Announcements Trials

Browse Landscape

Phase

Status

Completed 7 Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Melanoma 30 Neoplasm Metastasis 17 Skin Neoplasms 9 Leukemia, Myeloid, Acute 8 Neoplasms 7 Kidney Neoplasms 7 Ovarian Neoplasms 6 Carcinoma, Renal Cell 6 Carcinoma, Non-Small-Cell Lung 5 Stomach Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Pancreatic Neoplasms 4 Neuroblastoma 4 Lymphoma, Non-Hodgkin 4 Leukemia 4 Breast Neoplasms 4 Lymphoma 3 Lung Neoplasms 3 Congenital Abnormalities 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Unspecified Adult Solid Tumor, Protocol Specific 2 Triple Negative Breast Neoplasms 2 Sezary Syndrome 2 Rectal Neoplasms 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2

Interventions

Dexamethasone 29 Cyclophosphamide 21 Rituximab 17 Cytarabine 16 Bortezomib 13 Gemcitabine 12 fludarabine 11 Methotrexate 11 Lenalidomide 10 Filgrastim 10 Vincristine 9 Etoposide 9 pomalidomide 8 pembrolizumab 8 Paclitaxel 8 Azacitidine 8 venetoclax 7 carfilzomib 7 Doxorubicin 7 Docetaxel 7 Cyclosporine 7 Calcium Dobesilate 7 Antilymphocyte Serum 7 fludarabine phosphate 6 Topotecan 6 Temozolomide 6 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Mitoxantrone 6 daratumumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Recurrence × aldesleukin × Clear all

NCT04347616 2026-03-16

NK4AML

Radboud University Medical Center

Phase 1/2 Terminated

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡